Forbes December 10, 2025
The United States and United Kingdom agreed to a prescription drug deal last week that will ensure tariff-free U.K. exports of medicines, active pharmaceutical ingredients and medical devices to the U.S. for at least three years. In exchange, the U.K. commits to spending more on newly approved pharmaceuticals. One of the key features of the agreement is a 25% increase in the numeric value of the metric that helps decide whether a health intervention is worth the cost. But contrary to media reports this is not the same thing as a 25% hike in the price of new medicines, though it may make it easier for higher-priced drugs in future to pass muster with the national cost-effectiveness watchdog.
From April...
Today's Sponsors
Today's Sponsor